Maintenance fees coming due
6 maintenance fees come due in the 12 months from Nov 17, 2026, the next on Dec 20, 2026. Unpaid by Jun 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,679,164 | Preparation of Therapeutic Exosomes Using Membrane Proteins In force Fee due Dec 20, 2026 Lapses if unpaid Jun 21, 2027 · Low confidence | Lonza Sales AG | In force | Dec 20, 2026 | Jun 21, 2027 | Low confidence | |
| US 9,085,778 | Exosome transfer of nucleic acids to cells In force (reinstated) Fee due Jan 21, 2027 Lapses if unpaid Jul 21, 2027 · High confidence | Lonza Sales AG | In force (reinstated) | Jan 21, 2027 | Jul 21, 2027 | High confidence | |
| US 11,708,463 | Spray Drying Process for Low Aspect Ratio Particles Comprising Poly[(methyl Methacrylate)-Co-(methacrylic Acid)] In force Fee due Jan 25, 2027 Lapses if unpaid Jul 26, 2027 · High confidence | Lonza Sales AG | In force | Jan 25, 2027 | Jul 26, 2027 | High confidence | |
| US 10,370,663 | Delivery of Therapeutic Agent In force (reinstated) Fee due Feb 6, 2027 Lapses if unpaid Aug 6, 2027 · High confidence | Lonza Sales AG | In force (reinstated) | Feb 6, 2027 | Aug 6, 2027 | High confidence | |
| US 10,561,740 | Preparation of Therapeutic Exosomes Using Membrane Proteins In force Fee due Aug 18, 2027 Lapses if unpaid Feb 18, 2028 · Low confidence | Lonza Sales AG | In force | Aug 18, 2027 | Feb 18, 2028 | Low confidence | |
| US 11,925,954 | Flash Nozzle Assembly In force Fee due Sep 12, 2027 Lapses if unpaid Mar 13, 2028 · High confidence | Lonza Sales AG | In force | Sep 12, 2027 | Mar 13, 2028 | High confidence |
6 of 6 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.